Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

Q2 2026 Earnings Call November 14, 2025 4:30 PM ESTCompany ParticipantsWaqaas Al-Siddiq - Founder, President, CEO ...

Public meeting on Nov. 6 sees several people criticize town and GNWT for what’s been done since original advisory earlier ...

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Management believes this presentation enhances transparency and comparability by aligning the license-related economics with the Company’s recurring operations and long-term value creation strategy.

The annual event challenges doctoral candidates to present their complex research in just three minutes, using language ...

Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

Hydroponic Basil, Potted Herbs, and Wheatgrass Accelerate; International Nutraceutical Sales Nearly Double Year-Over-Year ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.